Teladoc Health, Inc.TDOCNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P38
Within normal range
vs 3Y Ago
-2.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -11.61% |
| Q3 2025 | 8.57% |
| Q2 2025 | 474.36% |
| Q1 2025 | -81.47% |
| Q4 2024 | -22.03% |
| Q3 2024 | 24.23% |
| Q2 2024 | 894.20% |
| Q1 2024 | -93.14% |
| Q4 2023 | 23.18% |
| Q3 2023 | 4.37% |
| Q2 2023 | 669.09% |
| Q1 2023 | -79.93% |
| Q4 2022 | 4.01% |
| Q3 2022 | -31.85% |
| Q2 2022 | 391.27% |
| Q1 2022 | -138.15% |
| Q4 2021 | 8.64% |
| Q3 2021 | 46.68% |
| Q2 2021 | 389.68% |
| Q1 2021 | 84.32% |
| Q4 2020 | -457.00% |
| Q3 2020 | -9.44% |
| Q2 2020 | 662.50% |
| Q1 2020 | -134.87% |
| Q4 2019 | 34.34% |
| Q3 2019 | 119.39% |
| Q2 2019 | 177.91% |
| Q1 2019 | -418.74% |
| Q4 2018 | -75.68% |
| Q3 2018 | 379.24% |
| Q2 2018 | 73.71% |
| Q1 2018 | -90.67% |
| Q4 2017 | 38.06% |
| Q3 2017 | -303.05% |
| Q2 2017 | 76.70% |
| Q1 2017 | -55.46% |
| Q4 2016 | 45.92% |
| Q3 2016 | -26.65% |
| Q2 2016 | 31.44% |
| Q1 2016 | -33.79% |